Streetbeat News

Stock Prices

INMB

INmune Bio has completed a blinded interim analysis of its Phase II Alzheimer's Disease trial, confirming the accuracy of sample size calculations and statistical power for the primary endpoint, EMACC.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:02 pm

ALLR

Allarity Therapeutics (NASDAQ:ALLR) has been granted a hearing before a Nasdaq Hearings Panel to present its plan for regaining compliance with NASDAQ listing requirements.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:02 pm

CRGY

Over the past three months, analysts have shared mixed opinions on Crescent Energy (NYSE:CRGY), with ratings ranging from bullish to indifferent. The average 12-month price target has decreased to $17.8 from $18.50. Key analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance. Crescent Energy has shown notable revenue growth but faces challenges in profitability, return on equity, and debt management.

Portfolio Pulse from Benzinga Insights

June 27, 2024 | 12:01 pm

BK

Over the past three months, four analysts have shared their insights on Bank of New York Mellon (NYSE:BK), with ratings ranging from bullish to indifferent. Analysts have set a 12-month average price target of $66.25, up 6.85% from the previous $62.00. Recent actions include rating upgrades and increased price targets from firms like Keefe, Bruyette & Woods, Jefferies, B of A Securities, and Evercore ISI Group.

Portfolio Pulse from Benzinga Insights

June 27, 2024 | 12:00 pm

PPBT

Purple Biotech shares are trading higher following the announcement of additional interim data from its Phase 2 pancreatic cancer study, showing consistent improvement in primary and secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:00 pm

DJT

Trump Media & Technology Group shares are trading higher ahead of tonight's presidential debate.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:58 am

IP

International Paper shares are trading higher after Suzano announced it will not pursue a transaction involving the company.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:57 am

IP

SUZ

Suzano shares are trading higher after the company announced it will not pursue a transaction involving International Paper.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:56 am

PPBT

Purple Biotech has reported interim results from its randomized Phase 2 pancreatic cancer study, showing consistent improvement in both primary and secondary endpoints.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:54 am

UBER

Uber Technologies Inc. (NYSE:UBER) has launched the 'One Less Car' trial to encourage drivers to use alternative transportation methods. The trial will run from July 22 to August 25 and will offer selected participants $1,000 to give up their cars for five weeks. This initiative aims to promote a car-light lifestyle and reintroduce UberX Share.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 11:54 am